Apricot Capital

Apricot Capital is a Shanghai-headquartered Chinese venture capital firm with a healthcare investment program spanning biotech, pharmaceutical therapeutics, and medical devices. The firm operates within China’s domestic healthcare investment ecosystem, where capital deployment is shaped by national priorities around biotech capability building, advanced therapeutic development, and medical device manufacturing localization. Its healthcare positioning is multi-vertical, covering both early therapeutic platforms and applied medical device companies pursuing the Chinese market.

Apricot Capital invests at seed, Series A, and Series B stages, with typical check sizes in the $5M to $25M range. Geographic activity is concentrated in China, with portfolio companies typically headquartered in major innovation hubs including Shanghai, Beijing, and the Yangtze River Delta region. Deal types include institutional equity rounds in early-stage biotech, therapeutic, and medical device companies, often syndicated with other Chinese institutional investors, family offices, and policy-aligned funds. Investments span pre-revenue therapeutic platforms and revenue-generating medical device businesses, reflecting a balanced exposure across the healthcare risk spectrum.

For founders, Apricot Capital offers institutional Chinese venture capital combined with deep linkages into the domestic healthcare commercialization ecosystem. The firm is most relevant to biotech, therapeutic, and medical device companies whose strategies are anchored in the Chinese market or that pursue China-centric clinical development and manufacturing. Engagement involves standard institutional diligence, board-level governance, and ongoing support on Chinese regulatory navigation and commercial scaling. Founders should expect a portfolio approach oriented toward domestic market depth rather than international expansion, with the firm best suited to teams that have native China presence or pursue Chinese market entry as a primary commercial objective.